ANTIGENICS INC. 20,000,000 Shares Of Common Stock At Market Issuance Sales AgreementAntigenics Inc /De/ • March 1st, 2010 • Biological products, (no disgnostic substances) • New York
Antigenics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC, a Delaware limited liability company (“MLV”), and Wm Smith & Co., a Colorado corporation (“Wm Smith” and together with MLV, the “Agents”), as follows:
